Diagnosing genital warts typically involves a visual examination by a healthcare professional. In some cases, additional tests such as vinegar solution application (which causes warts to turn white) or biopsy may be performed to confirm the diagnosis. Genital warts can appear weeks to months after HPV infection, and in some cases, individuals may not exhibit any symptoms. Treatment options for genital warts aim to remove the visible warts and manage the underlying HPV infection. Topical medications, such as imiquimod or podofilox, can be applied to the warts, promoting their elimination. Cryotherapy, where warts are frozen off, and surgical procedures like laser therapy or excision may also be utilized for wart removal. It is important to note that while treatments can remove visible warts, they do not cure the underlying HPV infection. Regular follow-up and monitoring are recommended, especially for individuals with high-risk HPV types. Moreover, vaccination against HPV is crucial for preventing new infections and reducing the overall burden of genital warts and associated cancers.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Gendered socioeconomic impacts of emerging infectious diseases: Insights from a mixed-methods study in Guinea
Stephanie Maltais, University of Montreal, Canada
Title : The role of social sciences in operationalizing the One Health approach: A case study of the DOPERAUS project in Guinea and the Democratic Republic of Congo
Stephanie Maltais, University of Montreal, Canada